Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema: The COLLIDE Trial

NCT02684084 is registered in ClinicalTrials.gov with North Toronto Eye Care Laser and Eye Specialists as lead sponsor.

NCT NCT02684084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02684084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema: The COLLIDE Trial
Lead sponsor
North Toronto Eye Care Laser and Eye Specialists
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2015
Completion date
December 31, 2016
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema